Catechol-o-methyltransferase inhibition with tolcapone reduces the ``wearing off'' phenomena and levodopa requirement in fluctuating parkinsonian patients - Bass,H.; Beiske,A.G.; Ghika,J. (J Neurol Neurosurg Psychiatry, 1997)